| Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy FA Howe, SJ Barton, SA Cudlip, M Stubbs, DE Saunders, M Murphy, ... Magnetic Resonance in Medicine: An Official Journal of the International …, 2003 | 744 | 2003 |
| Brain metabolite changes in cortical grey and normal‐appearing white matter in clinically early relapsing–remitting multiple sclerosis DT Chard, CM Griffin, MA McLean, P Kapeller, R Kapoor, AJ Thompson, ... Brain 125 (10), 2342-2352, 2002 | 365 | 2002 |
| Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume JM Stone, F Day, H Tsagaraki, I Valli, MA McLean, DJ Lythgoe, ... Biological psychiatry 66 (6), 533-539, 2009 | 285 | 2009 |
| Elevated white matter myo‐inositol in clinically isolated syndromes suggestive of multiple sclerosis KTM Fernando, MA McLean, DT Chard, DG MacManus, CM Dalton, ... Brain 127 (6), 1361-1369, 2004 | 272 | 2004 |
| Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis O Ciccarelli, CA Wheeler-Kingshott, MA McLean, M Cercignani, ... Brain 130 (8), 2220-2231, 2007 | 197 | 2007 |
| Imaging breast cancer using hyperpolarized carbon-13 MRI FA Gallagher, R Woitek, MA McLean, AB Gill, R Manzano Garcia, ... Proceedings of the National Academy of Sciences 117 (4), 2092-2098, 2020 | 192 | 2020 |
| Quantitative analysis of short echo time 1H‐MRSI of cerebral gray and white matter MA McLean, FG Woermann, GJ Barker, JS Duncan Magnetic Resonance in Medicine: An Official Journal of the International …, 2000 | 192 | 2000 |
| Quantifying normal human brain metabolism using hyperpolarized [1–13C] pyruvate and magnetic resonance imaging JT Grist, MA McLean, F Riemer, RF Schulte, SS Deen, F Zaccagna, ... Neuroimage 189, 171-179, 2019 | 187 | 2019 |
| Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy DE Saunders, FA Howe, A van den Boogaart, MA McLean, JR Griffiths, ... Stroke 26 (6), 1007-1013, 1995 | 184 | 1995 |
| Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis JM Stone, OD Howes, A Egerton, J Kambeitz, P Allen, DJ Lythgoe, ... Biological psychiatry 68 (7), 599-602, 2010 | 170 | 2010 |
| Short echo time single‐voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging–negative temporal lobe epilepsy: Different biochemical profile … FG Woermann, MA McLean, PA Bartlett, GJ Parker, GJ Barker, JS Duncan Annals of Neurology: Official Journal of the American Neurological …, 1999 | 167 | 1999 |
| Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR … P Kapeller, MA McLean, CM Griffin, D Chard, GJM Parker, GJ Barker, ... Journal of neurology 248, 131-138, 2001 | 166 | 2001 |
| Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy RJ Simister, MA McLean, GJ Barker, JS Duncan Neurology 61 (7), 897-902, 2003 | 156 | 2003 |
| Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis P Fusar-Poli, JM Stone, MR Broome, I Valli, A Mechelli, MA McLean, ... Archives of general psychiatry 68 (9), 881-890, 2011 | 139 | 2011 |
| Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis J Sastre-Garriga, GT Ingle, DT Chard, L Ramió-Torrentà, MA McLean, ... Archives of neurology 62 (4), 569-573, 2005 | 138 | 2005 |
| Advanced ovarian cancer: multiparametric MR imaging demonstrates response-and metastasis-specific effects E Sala, MY Kataoka, AN Priest, AB Gill, MA McLean, I Joubert, MJ Graves, ... Radiology 263 (1), 149-159, 2012 | 134 | 2012 |
| A comparison of quantitative methods for clinical imaging with hyperpolarized 13C‐pyruvate CJ Daniels, MA McLean, RF Schulte, FJ Robb, AB Gill, N McGlashan, ... NMR in Biomedicine 29 (4), 387-399, 2016 | 125 | 2016 |
| Metabolite changes in early relapsing–remitting multiple sclerosis: A two year follow–up study M Tiberio, DT Chard, DR Altmann, G Davies, CM Griffin, MA McLean, ... Journal of neurology 253, 224-230, 2006 | 116 | 2006 |
| Stents for blood vessels DJ Doorly, CG Caro, MA McLean US Patent 6,554,856, 2003 | 106 | 2003 |
| Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis A Egerton, JM Stone, CA Chaddock, GJ Barker, I Bonoldi, RM Howard, ... Neuropsychopharmacology 39 (12), 2891-2899, 2014 | 101 | 2014 |
